Companies House 2024-05-01 2025-04-30 false 11922541 2025-04-30 11922541 2024-05-01 2025-04-30 11922541 2023-05-01 2024-04-30 11922541 uk-bus:Director1 2024-05-01 2025-04-30 11922541 uk-bus:Director2 2024-05-01 2025-04-30 11922541 2024-05-01 2025-04-30 11922541 uk-bus:Micro-entities 2024-05-01 2025-04-30 11922541 uk-bus:FullAccounts 2024-05-01 2025-04-30 11922541 uk-bus:AuditExempt-NoAccountantsReport 2024-05-01 2025-04-30 11922541 2024-04-30 11922541 uk-core:WithinOneYear 2025-04-30 11922541 uk-core:WithinOneYear 2024-04-30 11922541 uk-core:AfterOneYear 2025-04-30 11922541 1 2024-05-01 2025-04-30 11922541 2 2024-05-01 2025-04-30 11922541 uk-core:AfterOneYear 2024-04-30 iso4217:GBP

Registered Number 11922541

KANDELIA PHARMA LIMITED

Micro-entity Accounts

30 April 2025

## KANDELIA PHARMA LIMITED Registered Number 11922541

## Micro-entity Balance Sheet as at 30 April 2025

| Notes | 2025 | 2024
--- | --- | --- | ---
|  | £ | £
Called up share capital not paid |  | - | -
Fixed Assets |  | 2,024,818 | 2,024,818
Current Assets |  | 313,420 | 255,923
Prepayments and accrued income |  | - | -
Creditors: amounts falling due within one year |  | (92,821) | (102,684)
Net current assets (liabilities) |  | 220,599 | 153,239
Total assets less current liabilities |  | 2,245,417 | 2,178,057
Creditors: amounts falling due after more than one year |  | (1,659,682) | (1,705,046)
Provisions for liabilities |  | 0 | 0
Accruals and deferred income |  | (4,173) | (2,161)
Total net assets (liabilities) |  | 581,562 | 470,850
Capital and reserves |  | 581,562 | 470,850

- For the year ending 30 April 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.
- The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
- The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
- The accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

Approved by the Board on 31 August 2025

And signed on their behalf by:
Nishma Patel, Director

Footnotes:

- Advances and credits
  As at 30th April 2025 company's bank borrowings secured on all tangible and intangible assets of the company were £672020 (2024: £725376)

## KANDELIA PHARMA LIMITED Registered Number 11922541

## Notes to the Micro-entity Accounts for the period ended 30 April 2025

1 Employees

| 2025 | 2024
--- | --- | ---
Average number of employees during the period | 2 | 2